R&D to Revenue
23.94%
Fiscal year · Period ending:

CLBT R&D to Revenue
What is r&d to revenue?
R&D spending as percentage of revenue.
CLBT r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it, in percentage points.
| Period ending | R&D to Revenue | Change |
|---|---|---|
| 23.9401% | −0.59 pts | |
| 24.53% | −1.43 pts | |
| 25.9561% | −3.83 pts | |
| 29.7874% | +3.17 pts | |
| 26.6161% | −1.28 pts | |
| 27.8981% | +0.80 pts | |
| 27.1003% | — |
Frequently asked questions: CLBT r&d to revenue
What is Cellebrite DI Ltd. (CLBT)'s current r&d to revenue?
Cellebrite DI Ltd. (CLBT)'s latest reported r&d to revenue (Fiscal year) is 23.94% as of Dec 31, 2025. R&D spending as percentage of revenue.
How much historical r&d to revenue data is available for CLBT?
Stock Alarm Pro provides 7 dated annual fiscal periods observations for Cellebrite DI Ltd. (CLBT)'s r&d to revenue, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.
How can I compare CLBT's r&d to revenue to peers or set an alert?
You can open CLBT's r&d to revenue in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on CLBT delivered by push, email, or phone call.
Explore More
Explore 130+ historical metrics & ratios
Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance